Georgia Allows Medical Cannabis Vaping as Expanded Law Takes Effect

Registered medical cannabis patients in Georgia can now vaporize their medicine, hold far more of it, and qualify under a broader set of conditions, as the state’s most significant cannabis expansion in a decade took effect Wednesday, July 1, 2026.

The changes flow from SB 220, the “Putting Georgia’s Patients First Act,” which Gov. Brian Kemp (R) signed on May 12, 2026. Passage was the easy part; the law’s provisions only became operative this week, and they reshape a program long considered among the most restrictive in the country.

What changes for patients

Patients 21 and older can now use medical cannabis through vaporization, a delivery method the state had never permitted. Smoking remains banned for everyone in the program, and vaporizing in public remains off-limits. The distinction matters most for people managing acute symptoms: inhaled cannabis works within minutes, while the oils, tinctures and capsules that made up Georgia’s old menu can take an hour or more to take hold.

The law also rewrites how the state measures a lawful supply. Georgia had capped medical products at 5 percent THC and allowed patients to keep up to 20 fluid ounces of “low THC oil.” Both limits are gone. In their place is a possession ceiling of 12,000 milligrams of total THC, with any single package capped at 1,200 milligrams. Shifting from a potency percentage to a milligram-based model is the change that opens the door to stronger, more clinically useful products than the diluted oils patients had been limited to. The ceiling also puts more onus on patients, who now have to track cumulative THC across every product they carry rather than a single oil bottle.

Eligibility widens too. SB 220 adds lupus as a qualifying condition and broadens several existing categories, removing the “severe” or “end-stage” language that had shut out patients with conditions such as Parkinson’s disease, ALS and multiple sclerosis until their illness advanced. It replaces Crohn’s disease with the broader “inflammatory bowel disease” and updates older AIDS language to cover HIV. The moves track a wider trend of cautious states loosening access, including Kentucky’s recent addition of more than a dozen qualifying conditions.

The law narrows patients’ legal risk as well. It scraps the old trafficking tiers tied to fluid-ounce quantities of oil, which carried steep mandatory-minimum sentences, and excludes lawful possession by cardholders from Georgia’s controlled-substances law.

A restrictive program, widened

Georgia has run one of the nation’s narrowest medical cannabis programs since lawmakers first authorized low-THC oil possession in 2015. A 2019 law created a way to actually buy the product, but sales did not begin until April 2023. Roughly 33,300 patients were registered as of mid-2025. The slow build is not unique to Georgia; neighboring Alabama only opened its first dispensary this year after a five-year delay.

That history is why national advocates had declined to count Georgia as a true medical marijuana state. With SB 220 in force, the Marijuana Policy Project now lists Georgia as the 41st state with a comprehensive medical cannabis program — a threshold it never met under the old low-THC framework. Kemp, who restated his opposition to recreational legalization when he signed the bill, cast the changes as meaningful for affected patients but modest in the national picture.

The expansion tightens one rule. A certifying physician must now maintain a principal practice in Georgia, a provision meant to shut down out-of-state telemedicine operations that had signed up thousands of patients. Visitors get limited cover: an out-of-state cardholder may possess medicine for up to 45 days in Georgia, as long as it stays in its original labeled packaging. The state’s supply still runs through six licensed producers feeding a limited network of dispensaries and pharmacies, a market that will have to scale up if the newly eligible patients arrive in force.

What patients and operators should watch

The legal change is live, but dispensary shelves will lag it. Vaporization products, including raw flower meant for home vaporizers, become available only after the Georgia Access to Medical Cannabis Commission sets rules for testing, labeling and packaging the new higher-potency formats. Operators expect those items to phase in over the coming months rather than arrive all at once.

Patients still register through the Georgia Department of Public Health, and physician certification remains the only way in. Smokable flower, pre-rolls and food-based edibles such as gummies stay prohibited, and nothing in the law touches recreational use, which is still illegal in the state.

The commission also picks up a new duty: public education about the program, including outreach to patients, physicians and law enforcement on who qualifies and how the expanded rules work. For a program that has drawn far fewer patients than its population would suggest, that mandate could matter as much as the product changes. Thousands of newly eligible Georgians benefit only if they know the door is now open.